SS Innovations acquires a US company and plans to export surgical robots built in India
Robotic surgery improves accuracy, adaptability, and control during procedures, but its uptake in low- and middle-income nations is fairly restricted, primarily because of the expense and lack of vision requirements.
admin
By acquiring a US company listed on NASDAQ, SS Innovations, a med-tech startup that recently unveiled India's first fully indigenous robotic surgery system, SSI Mantra, hopes to expand internationally.
The organization, led by robotic cardiac surgeon Dr. Sudhir Srivastava, announced on November 17 that it had acquired a controlling stake in the US-based Avra Medical Robotics, giving it access to the global capital and market.
The company is also hoping to collaborate with a number of India's public institutions to improve surgical outcomes for the country's underprivileged citizens.
According to Srivastava, "this acquisition would enable us access the global market and our innovation will be extensively adopted." "This acquisition will assist us to bring this Make in India technology to the global market since we know that the future of medical technology resides in the accuracy of surgery," the company said.
Srivastava claims that the acquisition gives the business access to open venues for fundraising.
"Typically, the listing procedure costs a lot of money and takes almost two years. However, this deal enables us to fund $100 million to $200 million quickly - I'm talking about months - Srivastava said.
Because of the demand for orders and the development of supply chains for infrastructure, he added, "that is a significant advantage, and even though we have launched some systems, we need to arrive at a completely different level."
The acquisition of Avra will enable the company to keep control while the product is created in India and has its headquarters here, according to Srivastava, who also stressed the importance of money. And, of course, we are absolutely trying to go global, he continued.
Surgical robots made in India
According to the company, SSI Mantra has more and better features and applications than current systems. The device will also help mainstream surgical practises in India and around the world in terms of precision and notable cost reduction, making pricey robotic surgery accessible to the general public.
While SSI Mantra is currently available at three private hospitals in India, one each in Delhi, Raipur, and Hyderabad, according to Srivastava, his business is also in discussions with a few government universities and hospitals to make it accessible to people with limited financial resources so they can access high-quality healthcare.
Benefits that are excessive
Robotic surgery, also known as robot-assisted surgery, enables medical professionals to carry out various difficult procedures with greater accuracy, adaptability, and control than is feasible with traditional methods.
It is frequently employed in minimally invasive surgery, which is done through tiny incisions, although it can also be applied in some types of open surgery.
According to doctors, robots enable even average surgeons to do operations with more precision and clinical success, while patients may spend less time in the hospital and recover more quickly.
According to Srivastava, SSI Mantra has also offered patients cost-effective ways to improve their surgical experiences for only an additional Rs 50–60,000 for the majority of procedures.
